Using Nanoparticle Tracking Analysis (NTA), we confirmed that the anti-CD235a immunocaptured RBC-EVs from human control and Parkinson’s disease plasma displayed a similar size distribution as those obtained from cultured RBCs in our previous study [53] (Supplemental Figure 1a-c). The gene discussed is GYPA; the disease is Parkinson disease.